Physician profile
Damon E Welch
NPI 1316029382
$921.66
in general payments reported to CMS, 2019-2025
12 companies · $61.12 in 2025
The $61.12 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.46 · 2020: $23.79 · 2022: $180 · 2023: $259 · 2024: $336 · 2025: $61.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $656.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $656.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $414.55 | 2023-2024 | Envista Mx60 Iol |
| Coopervision INC. | $107.01 | 2023-2024 | Myday Contact Lens, Misight Contact Lens |
| Johnson & Johnson Vision Care, INC. | $104.77 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $76.92 | 2022-2025 | Tecnis Iol |
| New World Medical,INC. | $38.58 | 2023 | |
| Sight Sciences, INC. | $37.81 | 2023-2025 | Omni Surgical System, Sion Surgical Instrument |
| Alcon Vision LLC | $36.95 | 2022 | |
| Alcon Research LLC | $28.62 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $23.79 | 2020 | |
| Ivantis, INC | $19.84 | 2019 | |
| Abbvie INC. | $19.82 | 2023 | Durysta |
| Akorn, INC. | $13.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Damon Welch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.